XML 16 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flow - USD ($)
9 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities        
Net loss including non controlling interest $ (65,798,667) $ (9,691,963) $ (14,201,151) $ (9,806,578)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 1,232,626 1,293,803 1,624,208 1,370,143
Accretion of interest on convertible note     0 0
Allowance for doubtful accounts 208,264 0 0 263,082
Stock based compensation 30,779,664 0    
Deferred income taxes 36,283 (42,729) (131,378) (37,090)
Unrealised foreign exchange loss/(profit) 628,435 8,417 9,184 23,170
Fair value losses in financial instruments carried at fair value 22,369,638 1,009,374 1,009,374 3,392,971
Gain on fair valuation of investments (1,812) 0    
Gain on sale of property and equipment 0 (495) (625) (173)
Expected credit loss (net of reversal) 208,264 0 0 263,082
Lease equalisation reserve 0 14,676 (9,675) 1,952
Impairment loss     919,517 101,578
Balances written off/(back) 0 209 7,164 38,217
Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions:        
Inventories 30,013 (29,079) (9,352) (55,989)
Income taxes, net 19,286 109,680 (55,766) 86,898
Accounts receivables, net 2,412,838 (170,992) (943,470) (318,885)
Prepayments and other assets (24,935,177) (1,290,384) (529,692) (1,237,401)
Accounts payable and accrued expenses and other current liabilities 19,656,629 1,730,544 4,193,438 1,998,781
Other liabilities (1,219,411) 87,564 571,519 113,271
Net cash used in operating activities (14,581,391) (6,971,375) (7,546,704) (4,066,053)
Cash flows from investing activities        
Purchase of property and equipment, intangible assets and goodwill (423,575) (326,972) (842,045) (1,081,295)
Proceeds from sale of property, plant and equipment 0 1,096 686 782
Acquisition of businesses (5,749,202) 0 0 (72,088)
Investment in mutual funds (500,000) 0    
Net cash used in investing activities (6,672,777) (325,876) (841,359) (1,152,601)
Cash flows from financing activities        
Proceeds from business combination 32,770 0    
Proceeds from issue of preferred stock 6,079,409 0 458,000 0
Proceeds from exercise of preferred share warrants     9,996 544,170
Proceeds from long-term borrowings 2,806,638 4,357,544 4,107,029 71,169
Repayments of long-term borrowings (1,025,884) (685,659) (612,645) (40,439)
Net proceeds/(payments) from short-term borrowings 10,702,721 4,573,698 4,398,343 277,036
Net cash generated from financing activities 18,595,654 8,245,583 8,360,723 851,936
Effect of exchange rate changes on cash and cash equivalents 108,532 (109,747) 72,752 (2,808)
Net (decrease)/increase in cash and cash equivalents (including restricted cash) (2,549,982) 838,585 45,412 (4,369,526)
Cash acquired in business combination 11,252,546 0 0 703,097
Cash and cash equivalents at the beginning of the period (including restricted cash) 1,131,830 1,086,418 1,086,418 4,752,847
Cash and cash equivalents at the end of the period (including restricted cash) 9,834,394 1,925,003 1,131,830 1,086,418
Reconciliation of cash and cash equivalents        
Cash and cash equivalents 9,406,697 1,283,615 589,340 913,636
Restricted cash 427,697 641,388 542,490 172,782
Total cash and cash equivalents 9,834,394 1,925,003 1,131,830 1,086,418
Supplemental disclosure of cash flow information        
Cash paid for interest, net of amounts capitalized 174,934 281,944 457,177 16,824
Cash paid for income taxes, net of refunds 0 22,115 $ 141,228 $ 65,831
Non-cash investing and financing activities        
Exercise of warrant for issuance of convertible preferred stock     103,159 10,804,399
Convertible preferred stock issued on conversion of convertible notes 0 6,441,014 $ 24,006,892 $ 117,012
Consideration payable in connection with acquisitions 1,850,384 602,093 243,036 1,032,633
Interest accrued on borrowings $ 451,805 $ 0 $ 257,188 $ 0